What is the global market size of Allergy Diagnostics Market?

Allergy Diagnostics Market was valued at USD 4.80 billion in 2021, and the market size is estimated to reach USD 10.03 billion by 2028, at a CAGR of 11.10% over the forecast period (2022-2028).

Who are the key vendors in the Global Allergy Diagnostics Market?

The global allergy diagnostics market is highly competitive and companies are actively involved in new product launches, strategic collaborations, acquisitions, and technological advancements to gain maximum market share. 'Thermo Fisher Scientific Inc., (US)', 'Siemens Healthineers (Germany)', 'Danaher (US)', 'Omega Diagnostics Group PLC (UK)', 'BioMérieux SA (France)', 'Romer Labs Division Holding (Austria)', 'EUROIMMUN Medizinische Labordiagnostika AG (Germany)', 'HollisterStier Allergy (US)', 'NEOGEN Corporation (US)', 'Minaris Medical America, Inc. (US)', 'Stallergenes Greer (UK)', 'HOB Biotech Group Corp., Ltd. (China)', 'HYCOR Biomedical (US)', 'R-Biopharm AG (Germany)', 'AESKU.GROUP GmbH (Germany)', 'ACON Laboratories, Inc. (US)'

What is the key driver of Global Allergy Diagnostics Market?

Rising environmental contamination is propelling the global allergy diagnostics market

What is the key market trend for Global Allergy Diagnostics Market?

Reagent rental agreements are gaining traction to reduce the high costs of allergy diagnostics. Reagent rental agreements are sales contracts between allergy diagnostic product manufacturers and end users (such as hospitals and diagnostic laboratories). The end user leases or purchases instruments at a subsidized rate under these agreements by engaging into a reagent-purchase contract with the manufacturer. This mutually advantageous agreement reduces the end user's initial capital commitment while assuring the manufacturer of long-term orders. In some circumstances, analyzers are rented to end users on a per-test basis. Reagent rental agreements and cost-per-test contracts provide considerable cost-cutting advantages to laboratories. They also assist laboratories in avoiding large fixed capital expenses connected with the acquisition of new equipment. These costs are significantly greater in high-volume laboratories than in regular laboratories. Furthermore, with the average contract lasting between 5 and 10 years, laboratories may stay up to speed on the newest advancements in allergy diagnostics. Some contracts incorporate service/maintenance costs in the entire cost, providing laboratories with extra savings.

Which region accounted for the largest share in Global Allergy Diagnostics Market?

In terms of revenue, North America led the global market in 2021 due to a high frequency of respiratory allergic illnesses, increased awareness of allergy diagnostics, and the use of in vitro blood testing. Due to the presence of a strong pharmaceutical sector and rising demand for treatments, Europe is likely to be the second-largest regional market. The region's expansion is also being fueled by an aging population and an increase in allergy disorders. Due to rapidly improving healthcare infrastructure, unmet clinical needs, and demand for minimally invasive diagnostic instruments, Asia Pacific is predicted to be the fastest-growing regional market, with a CAGR of 13.2% over the forecast period.

Allergy Diagnostics Market Size, Share, Growth Analysis, By Product(Consumables, Instruments (Immunoassay Analyzers, ELISA Analyzers, Luminometers), By Allergens(Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), By Test Type(Vivo Tests (Skin Prick Tests, Patch Tests, Other In Vivo Tests), In Vitro Tests), By End User(Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users), By Region - Industry Forecast 2024-2031

Report ID: SQSG35I2040 | Region: Global | Published Date: September, 2024
Pages: 165 | Tables: 123 | Figures: 73

Allergy Diagnostics Market Competitive Landscape

Allergy Diagnostics market Top Player’s Company Profiles

Danaher Corporation
Thermo Fisher Scientific Inc.
Canon, Inc. (Minaris Medical America, Inc.)
Siemens Healthineers AG
Eurofins Scientific
Revvity, Inc. (Euroimmun Medizinische Labor diagnostika AG)
BioMérieux SA
Stallergenes Greer Ltd.
Romer Labs Division Holding GmbH
HollisterStier Allergy
Omega Diagnostics Group PLC
HOB Biotech Group Corp., Ltd.
Hycor Biomedical
Lincoln Diagnostics, Inc.
R-Biopharm AG
Astra Biotech GmbH
Erba Group
AESKU.GROUP GmbH
ACON Laboratories, Inc.
Alcit India Pvt. Ltd.
Biopanda Reagents Ltd.
Bioside S.R.L.
Creative Diagnostic Medicare Pvt. Ltd.
DST Diagnostische Systeme & Technologien GmbH
Dr. Fooke Laboratorien GmbH

Allergy Diagnostics market Recent Development

In September 2023, Stallergenes Greer announced an agreement with Nestlé to connect the allergy oral immunotherapy treatment Palforzia®. With this agreement, Nestlé will get momentous royalties and payments from Stallergenes Greer. There will be an ordinary period to confirm continuity of business and offer unbroken access to patients for treatments.
In June 2023, EUROIMMUN, a subsidiary of Revvity Incorporation launched a novel automated system for (IIFT) indirect immunofluorescence test, named UNIQO 160 (CE-IVDR) for diagnosis of autoimmune diseases. It is an all-inclusive solution that automates the whole IIFT procedure, starting from sampling to image analysis and offers reliable and fast results.
In March 2023, Thermo Fisher Scientific declared that it increased the availability of ImmunoCAPTM Specific IgE tests to a greater number of patients in the United States. These ImmunoCAPTM tests are currently made available to individuals at Kroger Health’s The Little Clinic LLC locations via blood sample taken on site.

Allergy Diagnostics Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Allergy Diagnostics Market size was valued at around USD 4.3 billion in 2022 and is expected to rise from USD 4.8 billion in 2023 to reach a value of USD 11.1 billion by 2031, at a CAGR of 11% over the forecast period (2024–2031).

The competitive landscape of the global allergy diagnostics market is differentiated by the amalgamation of emerging companies and well-established players with ongoing strategic partnerships and innovations, reshaping the market. Prominent players like Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, and Roche are focusing on in vitro diagnostics, comprehensive allergen testing competencies, and improved diagnostic tests and platforms for the detection of allergies. Furthermore, small enterprises and progressing companies are emphasizing niche products or modernized testing techniques like digital health solutions and molecular diagnostics. To boost rankings, established companies are heavily investing in R&D, engaging in collaborations, and increasing their geographic presence. 'Danaher Corporation ', 'Thermo Fisher Scientific Inc. ', 'Canon, Inc. (Minaris Medical America, Inc.) ', 'Siemens Healthineers AG ', 'Eurofins Scientific ', 'Revvity, Inc. (Euroimmun Medizinische Labor diagnostika AG) ', 'BioMérieux SA ', 'Stallergenes Greer Ltd. ', 'Romer Labs Division Holding GmbH ', 'HollisterStier Allergy ', 'Omega Diagnostics Group PLC ', 'HOB Biotech Group Corp., Ltd. ', 'Hycor Biomedical ', 'Lincoln Diagnostics, Inc. ', 'R-Biopharm AG ', 'Astra Biotech GmbH ', 'Erba Group ', 'AESKU.GROUP GmbH ', 'ACON Laboratories, Inc. ', 'Alcit India Pvt. Ltd. ', 'Biopanda Reagents Ltd. ', 'Bioside S.R.L. ', 'Creative Diagnostic Medicare Pvt. Ltd. ', 'DST Diagnostische Systeme & Technologien GmbH ', 'Dr. Fooke Laboratorien GmbH'

The inclination towards personalized medicine is notably impacting allergy diagnostics. There is an increase demand for allergy tests that offer deep vision into personal sensitivities, enabling for more customized and personalized treatment decisions. Current research in detecting certain biomarkers associated with allergies improves the ability to create tailored treatment tactics, thus impacting the market growth.

Mounting Use of Molecular Diagnostics: Molecular diagnostic techniques like allergen component testing and next-generation sequencing are gaining prominence. These techniques enable more accurate detection of certain allergens at molecular stage. This trend improves precision of diagnostics, allowing better customized treatment plans depending on patient sensitivities. This ultimately results in better patient results. The commonly used molecular diagnostic methods include ELISA, PCR, and NHS.

Region-wise, North America dominated the market in the previous years and is expected to lead over the forecast period owing to rising incidences of allergies, improved healthcare infrastructure, and education and strong awareness. The region reports a higher number of allergic conditions as compared to other regions. These comprise various food allergies, allergic rhinitis, asthma, and more, which demand on reliable diagnostic facilities a large scale. Also, North America holds a well-established healthcare infrastructure with easy access to superior diagnostic techniques and an expert workforce. This streamlines accuracy and time testing. Also, the public awareness regarding allergies is higher than other regions, resulting in proactive medical industry seeking high demand for testing. The key players profiled in the region include Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, Roche Diagnostics, ALK-Abelló, and more.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Allergy Diagnostics Market Competitive Landscape

Allergy Diagnostics Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Allergy Diagnostics Market?

Who are the key vendors in the Allergy Diagnostics Market?

What is the key driver of Allergy Diagnostics Market?

What is the key market trend for Allergy Diagnostics Market?

Which region accounted for the largest share in Allergy Diagnostics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300